Aeterna Zentaris Dividend
Dividend criteria checks 0/6
Aeterna Zentaris does not have a record of paying a dividend.
Key information
n/a
Dividend yield
n/a
Payout ratio
Industry average yield | 2.9% |
Next dividend pay date | n/a |
Ex dividend date | n/a |
Dividend per share | n/a |
Earnings per share | -US$3.41 |
Dividend yield forecast in 3Y | n/a |
Recent dividend updates
No updates
Recent updates
Aeterna Zentaris to regain full rights to Macrilen oral test from Novo Nordisk
Aug 29Aeterna slips ~10% after announcing date of reverse stock split
Jul 19Aeterna Zentaris names Michael Teifel as chief scientific officer
May 03Aeterna Zentaris (AEZS) inks option agreement to evaluate potential COVID-19 vaccine, shares up 53%
Feb 02Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if AEZS's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if AEZS's dividend payments have been increasing.
Dividend Yield vs Market
Aeterna Zentaris Dividend Yield vs Market |
---|
Segment | Dividend Yield |
---|---|
Company (AEZS) | n/a |
Market Bottom 25% (US) | 1.6% |
Market Top 25% (US) | 4.8% |
Industry Average (Biotechs) | 2.9% |
Analyst forecast in 3 Years (AEZS) | n/a |
Notable Dividend: Unable to evaluate AEZS's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate AEZS's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate AEZS's payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as AEZS has not reported any payouts.